CORC

在结果中检索

CORC

浏览/检索结果: 共47条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer 期刊论文
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 卷号: 14
作者:  Yan, Min;  Yuan, Peng;  Ouyang, Quchang;  Cheng, Ying;  Han, Guohui
收藏  |  浏览/下载：25/0  |  提交时间：2022/12/23
Penpulimab plus gemcitabine in combination with cisplatin or anlotinib as first-line treatment for metastatic nasopharyngeal carcinoma (M NPC): A phase II study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Huang, Shuang;  Chen, Xiaozhong;  Qu, Song;  Qu, Shenhong;  Han, Yaqian
收藏  |  浏览/下载：10/0  |  提交时间：2022/12/23
Original Anti-PD1 checkpoint inhibitor with or without chemotherapy for patients with recurrent and metastatic nasopharyngeal carcinoma 期刊论文
TRANSLATIONAL ONCOLOGY, 2021, 卷号: 14
作者:  Jin, Ting;  Zhang, Qun;  Jin, Qi-Feng;  Hua, Yong-Hong;  Chen, Xiao-Zhong
收藏  |  浏览/下载：16/0  |  提交时间：2022/01/25
Optimal induction chemotherapeutic regimen followed by concurrent chemotherapy plus intensity-modulated radiotherapy as first-line therapy for locoregionally advanced nasopharyngeal carcinoma 期刊论文
MEDICINE, 2020, 卷号: 99
作者:  Wang, Fangzheng;  Jiang Chuner;  Wang Lei;  Yan Fengqin;  Ye Zhimin
收藏  |  浏览/下载：29/0  |  提交时间：2020/11/30
CTONG 1103: Erlotinib versus gemcitabine plus cisplatin as neo-adjuvant treatment for stage IIIA-N2 EGFR-mutation non- small cell lung cancer (EMERGING): A randomised study 会议论文
作者:  Zhong, W-Z.;  Wu, Y-L.;  Chen, K-N.;  Chen, C.;  Gu, C-D.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
A phase II randomized trial of gemcitabine plus cisplatin(GP) vs. gemcitabine plus carboplatin (GC) as the first-line treatment for patients with metastatic triple negative breast cancer 会议论文
作者:  Gong, Chengcheng;  Cao, Enying;  Wang, Zhonghua;  Zhang, Jian;  Wang, Leiping
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
Biomarker assessment of the CBCSG006 trial: a randomized phase III trial of cisplatin plus gemcitabine compared with paclitaxel plus gemcitabine as first-line therapy for patients with metastatic triple-negative breast cancer 期刊论文
ANNALS OF ONCOLOGY, 2018, 卷号: 29, 期号: 8
作者:  Zhang, J.;  Lin, Y.;  Sun, X. J.;  Wang, B. Y.;  Wang, Z. H.
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
CTONG 1103: Erlotinib versus gemcitabine plus cisplatin as neo-adjuvant treatment for stage IIIA-N2 EGFR-mutation non- small cell lung cancer (EMERGING): A randomised study 会议论文
作者:  Zhong, W-Z.;  Wu, Y-L.;  Chen, K-N.;  Chen, C.;  Gu, C-D.
收藏  |  浏览/下载：9/0  |  提交时间：2019/11/19
Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study 期刊论文
European Journal of Cancer, 2018, 卷号: Vol.100, 页码: 1-7
作者:  Xinan Sheng;  Dengfeng Cao;  Jianlin Yuan;  Fangjian Zhou;  Qiang Wei
收藏  |  浏览/下载：5/0  |  提交时间：2019/02/25
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials 期刊论文
LANCET ONCOLOGY, 2018, 卷号: Vol.19 No.10, 页码: 1338-1350
作者:  Fang, Wenfeng;  Yang, Yunpeng;  Ma, Yuxiang;  Hong, Shaodong;  Lin, Lizhu
收藏  |  浏览/下载：10/0  |  提交时间：2019/02/25

©版权所有 ©2017 CSpace - Powered by CSpace